CHER@NOS
A Multicenter Phase II Study of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation in Patients With Non-resectable Stage III Non-Small-Cell-Lung Cancer
Sponsor study identifier
interventional
77
1 country
3
Study Start
January 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2006
Actual (reported)Study Completion
November 2006
Actual (reported)The aim of this study is to evaluate whether by combining a carboplatin-gemcitabine based induction chemotherapy with weekly cisplatin during standard thoracic radiotherapy it is possible to obtain optimal efficacy with minimal toxicity. Patients will be treated with 3 cycles of induction chemotherapy, unless there is the occurrence of early intrathoracic progression of disease. The induction chemotherapy is then to be followed by chemo-radiotherapy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2006
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2003
Date type not reportedThis date has not been verified as actual or estimated.
November 2006
Actual (reported)November 2006
Actual (reported)April 18, 2007
Actual (reported)April 20, 2007
Actual (reported)2-year survival rates
Response rate
Time to intrathoracic failure
Overall survival
Toxicity of induction chemotherapy
Toxicity of chemo-radiotherapy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
carboplatin/gemcitabine
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordTreatment and procedure
cisplatin/radiation therapy
The registry names a treatment alongside a procedure. This entry does not establish their timing or actual administration.
View registry recordZNA Middelheim
Antwerp, Antwerp, Belgium
University Hospital Antwerp
Edegem, Antwerp, Belgium
Sint Augustinus Ziekenhuis
Wilrijk, Antwerp, Belgium
Paul R Germonpre
Universiteit Antwerpen
First Submitted
April 18, 2007
First Posted
April 20, 2007
Study Start
January 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2006
Actual (reported)Contact the study team to confirm eligibility.
Study Completion
November 2006
Actual (reported)Last Updated
July 12, 2013
Record last verified: 2013-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: